Lota A S, Gatehouse P D, Mohiaddin R H
Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, National Heart and Lung Institute, Imperial College, Sydney Street, London, SW3 6NP, UK.
Heart Fail Rev. 2017 Jul;22(4):431-440. doi: 10.1007/s10741-017-9616-5.
Cardiovascular magnetic resonance (CMR) is a versatile imaging modality that enables aetiological assessment and provides additional information to that of standard echocardiography in a significant proportion of patients with heart failure. In addition to highly accurate and reproducible assessment of ventricular volumes and replacement fibrosis, multiparametric mapping techniques have rapidly evolved to further expand the diagnostic and prognostic applications in various conditions ranging from acute inflammatory and ischaemic cardiomyopathy, to cardiac involvement in systemic diseases such as sarcoidosis and iron overload cardiomyopathy. In this review, we discuss the established role of T2* imaging and rapidly evolving clinical applications of myocardial T2 mapping as quantitative adjuncts to established qualitative imaging techniques.
心血管磁共振成像(CMR)是一种多功能成像方式,能够进行病因评估,并在相当一部分心力衰竭患者中提供超出标准超声心动图的额外信息。除了对心室容积和替代性纤维化进行高度准确且可重复的评估外,多参数成像技术也在迅速发展,以进一步扩大其在从急性炎症性和缺血性心肌病到结节病和铁过载心肌病等全身性疾病累及心脏等各种病症中的诊断和预后应用。在本综述中,我们讨论了T2*成像的既定作用以及心肌T2成像作为既定定性成像技术的定量辅助手段的快速发展的临床应用。